Report Detail
Cancer Vaccines Market, Pipeline Analysis Report 2020
- RnM4214066 |
- 23 September, 2020 |
- Global |
- 115 Pages |
- DPI Research |
- Medical Devices & Consumables
“Global Cancer Vaccines market size is expected to surpass US$ 8.5 Billion by 2025”
Report Scope:
• Detailed Insights of the Introduction to Cancer Vaccines and Mechanism of Cancer Vaccines
• The Market Size of the Global Cancer Vaccines Market with Five Years Forecast
• The Market Size of the 4 Leading Cancer Vaccines with Five Years Forecast
• Provides Comprehensive Insights on the Funding of the Cancer Vaccines Research
• Investigates the Key Growth Drivers and Restraints of the Global Cancer Vaccines Market
• Provides Key Trends with Respect to Collaboration Deals, Merger & Acquisitions, Partnership Deals, and Licensing Agreement
• Detailed Insights of the Regulatory Framework Including the Approval Process and an Overview of the Regulatory Authorities in the United States, EU, and Japan
• A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Sales Value Analysis, and Recent Development
• An Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent Development
“Cancer Vaccines Market, Pipeline Analysis Report, 2020” provides a comprehensive analysis of the fast-evolving, high-growth global cancer vaccines market. The report offers the foremost up-to-date industry data on the specific market situation and future outlook for the global cancer vaccines market. The report provides historical market data for 2015 – 2019, and forecasts from 2020 till 2025.
The report contains a granular evaluation of the prevailing enterprise conditions, market demands, reveal facts in the marketplace, revenues, and offers forecasts through 2025. The report presents clear perception into current and future developments of the global cancer vaccines market.
The report explores detailed insights into the introduction to cancer vaccines and the mechanism of cancer vaccines. The report additionally provides a detailed evaluation of the leading 4 key marketed cancer vaccines market assessments globally, data from 2015 to 2019, and forecasts to 2025. The report reviews a clear insight into the funding of the cancer vaccines studies. The report additionally investigates special insights about the regulatory landscape which include the approval system and an overview of the regulatory authorities in the United States, EU, and Japan.
Key developments of collaboration, partnerships, merger & acquisition, and licensing settlement are analyzed with details. The report additionally examines the principle marketplace growth drivers and restraining forces and also offers an all-round future outlook.
The report concludes with the profiles of the key players in the global cancer vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, vaccines revenue analysis, and recent development.
Other emerging players are making novel era-based vaccines that are in all possibility to have an effect on the market share during the forecast duration. The emerging players are evaluated on various parameters such as business overview, promising vaccines in the clinical development with the current stage of clinical evaluation, vaccines target, platform technology, and recent developments.
The following 4 leading vaccines of the global cancer vaccines market are detailed with market size and five-year forecast:
• Gardasil/Gardasil 9
• Cervarix
• Provenge
• Imlygic
The foremost companies dominating this market for its products, offerings, and non-stop product trends are:
• Amgen
• Merck & Co., Inc
• GlaxoSmithKline (GSK)
• Dendreon Pharmaceuticals (Sanpower Group)
• GeoVax,Inc
• Moderna, Inc
• Flow Pharma, Inc
• Polynoma LLC
• IO Biotech
• OncoPep, Inc
• Medigen, Inc
• ViciniVax
• ImmuneTune
• Treos Bio Limited
• EpiThany
• CureVac AG
• DCprime
• Vaximm AG
• AdaptVac
• MimiVax LLC
• Agenus, Inc
• AlphaVax, Inc
• Genexine
• GlobeImmune, Inc
• Ubivac, Inc
• Vaccinogen, Inc
• Genocea Biosciences, Inc
• Northwest Biotherapeutics, Inc
• OncBioMune Pharmaceuticals, Inc
• Inovio Pharmaceuticals, Inc
• Enochian Biosciences
• Eu Biologics Co., Ltd.
• EVOQ Therapeutics
• Heat Biologics, Inc
• Scancell Holdings PLC
• Anixa Biosciences, Inc
• PDC*line Pharma
• Elios Therapeutics, LLC
• OSE Immunotherapeutics
The Report Helps Solution the Following Questions:
• What is the current size of the overall global cancer vaccines market? How much will this market be worth from 2020 to 2025?
• What are the key marketed cancer vaccines? What are their revenue potentials to 2025?
• What are the main drivers and restraints in the global cancer vaccines market?
• What are the major deals happenings in the global cancer vaccines market?
• Who are the top market players and what are their happenings, vaccines revenue, current developments, and scenarios?
• What are some of the most prominent cancer vaccines currently in clinical development? What are their happenings, platform technology, and current developments?
1. Executive Summary
2. Introduction to Cancer Vaccines
3. Mechanism of Cancer Vaccines
4. Global Cancer Vaccines Market Size and Forecast (2015 – 2025)
5. Key Marketed Cancer Vaccines Market Value (2015 – 2025)
- 5.1 Gardasil/Gardasil 9
- 5.2 Cervarix
- 5.3 Provenge
- 5.4 Imlygic
6. Key Market Drivers and Inhibitors of the Cancer Vaccines Market
- 6.1 Key Market Drivers
- 6.2 Key Market Inhibitors
7. Funding in the Cancer Vaccines Research
8. Major Deals and Agreement Happenings in the Cancer Vaccines Market
- 8.1 Collaboration Deals
- 8.2 Licensing Agreement
- 8.3 Partnership Deals
- 8.4 Merger & Acquisitions
9. Regulatory Environment – Cancer Vaccines Approval Process
- 9.1 United States
- 9.2 Europe
- 9.3 Japan
10. Key Players Analysis
- 10.1 Merck & Co., Inc.
- 10.1.1 Business Overview
- 10.1.2 Vaccines Portfolio
- 10.1.3 Recent Development
- 10.2 GlaxoSmithKline (GSK)
- 10.2.1 Business Overview
- 10.2.2 Vaccines Portfolio
- 10.3 Dendreon Pharmaceuticals (Sanpower Group)
- 10.3.1 Business Overview
- 10.3.2 Vaccines Portfolio
- 10.3.3 Recent Development
- 10.4 Amgen
- 10.4.1 Business Overview
- 10.4.2 Vaccines Portfolio
- 10.4.3 Recent Development
11. Emerging Players Analysis
- 11.1 Genocea Biosciences,Inc
- 11.1.1 Business Overview
- 11.1.2 Promising Cancer Vaccines in the Clinical Development
- 11.1.3 Recent Development
- 11.2 GeoVax, Inc
- 11.2.1 Business Overview
- 11.2.2 Promising Cancer Vaccines in the Clinical Development
- 11.2.3 Recent Development
- 11.3 Moderna, Inc
- 11.3.1 Business Overview
- 11.3.2 Promising Cancer Vaccines in the Clinical Development
- 11.3.3 Recent Development
- 11.4 Northwest Biotherapeutics, Inc
- 11.4.1 Business Overview
- 11.4.2 Promising Vaccines in the Clinical Development
- 11.4.3 Recent Development
- 11.5 OncBioMune Pharmaceuticals, Inc
- 11.5.1 Business Overview
- 11.5.2 Promising Vaccines in the Clinical Development
- 11.5.3 Recent Development
- 11.6 Inovio Pharmaceuticals, Inc
- 11.6.1 Business Overview
- 11.6.2 Promising Cancer Vaccines in the Clinical Development
- 11.6.3 Recent Development
- 11.7 Enochian Biosciences
- 11.7.1 Business Overview
- 11.7.2 Promising Cancer Vaccines in the Clinical Development
- 11.8 Flow Pharma, Inc
- 11.8.1 Business Overview
- 11.8.2 Promising Cancer Vaccines in the Clinical Development
- 11.8.3 Recent Development
- 11.9 Polynoma LLC
- 11.9.1 Business Overview
- 11.9.2 Promising Cancer Vaccines in the Clinical Development
- 11.9.3 Recent Development
- 11.10 IO Biotech
- 11.10.1 Business Overview
- 11.10.2 Promising Cancer Vaccines in the Clinical Development
- 11.10.3 Recent Development
- 11.11 Eu Biologics Co., Ltd.
- 11.11.1 Business Overview
- 11.11.2 Promising Cancer Vaccines in the Clinical Development
- 11.12 OncoPep, Inc
- 11.12.1 Business Overview
- 11.12.2 Promising Cancer Vaccines in the Clinical Development
- 11.12.3 Recent Development
- 11.13 Medigen, Inc
- 11.13.1 Business Overview
- 11.13.2 Promising Cancer Vaccines in the Clinical Development
- 11.14 EVOQ Therapeutics
- 11.14.1 Business Overview
- 11.14.2 Promising Cancer Vaccines in the Clinical Development
- 11.15 Heat Biologics, Inc
- 11.15.1 Business Overview
- 11.15.2 Promising Cancer Vaccines in the Clinical Development
- 11.15.3 Recent Development
- 11.16 ViciniVax
- 11.16.1 Business Overview
- 11.16.2 Promising Cancer Vaccines in the Clinical Development
- 11.17 ImmuneTune
- 11.17.1 Business Overview
- 11.17.2 Promising Cancer Vaccines in the Clinical Development
- 11.18 Elios Therapeutics LLC
- 11.18.1 Business Overview
- 11.18.2 Promising Cancer Vaccines in the Clinical Development
- 11.18.3 Recent Development
- 11.19 Treos Bio Limited
- 11.19.1 Business Overview
- 11.19.2 Promising Cancer Vaccines in the Clinical Development
- 11.19.3 Recent Development
- 11.20 Scancell Holdings PLC
- 11.20.1 Business Overview
- 11.20.2 Promising Cancer Vaccines in the Clinical Development
- 11.20.3 Recent Development
- 11.21 EpiThany
- 11.21.1 Business Overview
- 11.21.2 Promising Cancer Vaccines in the Clinical Development
- 11.21.3 Recent Development
- 11.22 CureVac AG
- 11.22.1 Business Overview
- 11.22.2 Promising Cancer Vaccines in the Clinical Development
- 11.22.3 Recent Development
- 11.23 DCprime
- 11.23.1 Business Overview
- 11.23.2 Promising Cancer Vaccines in the Clinical Development
- 11.23.3 Recent Development
- 11.24 Vaximm AG
- 11.24.1 Business Overview
- 11.24.2 Promising Cancer Vaccines in the Clinical Development
- 11.24.3 Recent Development
- 11.25 Anixa Biosciences, Inc
- 11.25.1 Business Overview
- 11.25.2 Promising Cancer Vaccines in the Clinical Development
- 11.25.3 Recent Development
- 11.26 AdaptVac
- 11.26.1 Business Overview
- 11.26.2 Promising Cancer Vaccines in the Clinical Development
- 11.26.3 Recent Development
- 11.27 PDC*line Pharma
- 11.27.1 Business Overview
- 11.27.2 Promising Cancer Vaccines in the Clinical Development
- 11.27.3 Recent Development
- 11.28 MimiVax LLC
- 11.28.1 Business Overview
- 11.28.2 Promising Cancer Vaccines in the Clinical Development
- 11.28.3 Recent Development
- 11.29 Agenus, Inc
- 11.29.1 Business Overview
- 11.29.2 Promising Cancer Vaccines in the Clinical Development
- 11.30 AlphaVax, Inc
- 11.30.1 Business Overview
- 11.30.2 Promising Cancer Vaccines in the Clinical Development
- 11.31 Genexine
- 11.31.1 Business Overview
- 11.31.2 Promising Cancer Vaccines in the Clinical Development
- 11.31.3 Recent Development
- 11.32 GlobeImmune, Inc
- 11.32.1 Business Overview
- 11.32.2 Promising Cancer Vaccines in the Clinical Development
- 11.33 Ubivac, Inc
- 11.33.1 Business Overview
- 11.33.2 Promising Cancer Vaccines in the Clinical Development
- 11.34 Vaccinogen, Inc
- 11.34.1 Business Overview
- 11.34.2 Promising Cancer Vaccines in the Clinical Development
- 11.35 OSE Immunotherapeutics
- 11.35.1 Business Overview
- 11.35.2 Promising Cancer Vaccines in the Clinical Development
Summary:
Get latest Market Research Reports on Cancer Vaccines. Industry analysis & Market Report on Cancer Vaccines is a syndicated market report, published as Cancer Vaccines Market, Pipeline Analysis Report 2020. It is complete Research Study and Industry Analysis of Cancer Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
